[e-drug] MeTA launch at WHO Assembly Geneva 21 May 1300 Salle XXII

e-drug
1

E-DRUG: MeTA launch at WHO Assembly Geneva 21 May 1300 Salle XXII
-----------------------------------------------------------------
[Invitation for those E-druggers in Geneva; WB]

The Medicines Transparency Alliance: Making a Difference to People’s
Health

Place: Room XXII Palais des Nations, Geneva
Time & date: 13.00-14.30 Wednesday 21 May 2008 (a light lunch will be
available)

The Medicines Transparency Alliance (MeTA) is a global alliance
involving governments, business and civil society leaders, initially
financed by the UK Department for International Development (DFID) and
working in collaboration with the World Health Organization (WHO) and
the World Bank. This lunchtime meeting will be an opportunity to learn
more about MeTA’s programme to improve transparency and accountability
in the pharmaceutical market, and increase access to essential
medicines. It is beginning a pilot phase in seven countries – Ghana,
Jordan, Kyrgyzstan, Peru, The Philippines, Uganda and Zambia.

It will also be an opportunity to learn more about the WHO programme –
Good Governance for Medicines – which currently operates in 27
countries, and is a complementary initiative, also seeking to increase
access to quality essential medicines, through better transparency and
accountability.

Introductory remarks by:
• Sir Liam Donaldson, Chief Medical Officer, Department of Health,
United Kingdom
• Dr Carissa Etienne, Assistant Director General, Health Systems and
Services, WHO

A multi-stakeholder panel will provide further insights into both
programmes and will include presentations and discussion by:
• Hon. Dr Francisco Duque, Secretary of Health, Philippines
• Dr Chanvit Tharathep, Director Bureau of Health Services System
Development, Ministry of Public Health, Thailand
• Dr Hans Hogerzeil, Director, Department of Medicines Policy and
Standards, WHO
• Mrs Guitelle Baghdadi, Coordinator, Good Governance for Medicines
Programme, WHO
• Dr Harvey Bale, Director-General of the International Federation of
Pharmaceutical Manufactures and Associations
• Marg Ewen, Coordinator, WHO/HAI Project on Medicine Prices, Health
Action International
• Andrew Chetley, Communication Director, MeTA Secretariat
• Wilbert Bannenberg, Technical Director, MeTA Secretariat

Chair: Garth Singleton, Executive Director, MeTA Secretariat.

Supported by: DFID, MeTA
in collaboration with: WHO, World Bank

For further information: www.MedicinesTransparency.org

---
Wilbert Bannenberg,
Technical Director, Medicines Transparency Alliance (MeTA)
Email: wilbert@metasecretariat.org

**In Switzerland 19-23 May 2008**
Mobile +41-79-7679945